Do You Know What Sales and Marketing Activities Are Providing What Financial Results?

Can you prove which of your Pharmaceutical Marketing Activities are creating maximum brand sales, now and in the near future?

The Pharmaceutical Industry is under significant pressure to consider its costs very carefully. Since marketing budgets often represent a major proportion of a company's cost base, they can easily become the target of budget cuts. Although marketing investments are profitable, in the main, returns are now under intense scrutiny, with all budgets being squeezed. The pressure to measure marketing return and effectiveness has never been stronger. Currently, much budget is spent despite marketers being unable to identify which combination of activities has the greatest growth potential, and without knowing what specific effect individual activities are having on market share.

Because of this drive for marketing accountability, Return On Investment (ROI) techniques have become the focus of much attention and are frequently used to guide decisions on budget allocation. ROI techniques can include econometrics, promotional response curves and other predictive models. Unfortunately, many of these techniques utilize either historical or analogue data, and history does a poor job of pinpointing the way forward in an ever-changing marketplace like Pharma. You may know what financial result you got, but is that enough?

How Do You Know That The Results Will Continue If You Do The Same Thing Next Time?

The history does not equal the future. Models looking at the past could be analogised to trying to drive by looking in the rear view mirror. You are going to crash. You need to look at where you are now, use current market data, then look ahead and see what changes are coming and build these into the mathematical models. Although models using historical or analogue data are proven to be increasingly inaccurate, there are now next generation approaches available that can help a company determine where and how its marketing activities can work together and which synergistic combinations will deliver profitable value growth with a high degree of accuracy.

Improve Your Bottom Line Marketing Results Using Analytics With Proven Data of 94.8% Accuracy

Only one analytics system can provide a highly accurate solution to your Pharmaceutical Marketing issues. The Eularis 94.8 Analytics System offers you the highest degree of accuracy in the Pharmaceutical Market today by analyzing current real brand data (not historical data or analogue data which are both, by their very nature, flawed). The secret? Five years of R & D into data collection methodology combined with rigorous analytical testing to see which data collection techniques worked to create accuracy results. The results had to be validated against the real results taken, so this took several years to ensure the accuracy. Using this next generation analytics approach will allow you to:

• Identify all factors really influencing prescriber behavior the most
• Evaluate which messages are having the most impact on actual prescribing
• Quantify the financial impact from each marketing program
• Identify which elements of each program are having most actual prescribing impact
• Determine most effective mix of sales, medical education, advertising, PR, eActivities, etc. for optimal market share growth
• Forecast brand performance based on investment assumptions and market dynamics
• Highlight rep quality differences across brands and companies
• Provide Agency League Tables [according to which agencies activities are having most actual prescribing impact]
• Optimize all relevant resources for a brand or portfolio across multiple activities and geographies

Why 94.8?

We get asked this a lot! The reason we call our analytics 94.8 is because one of our Clients told us that they were going to back-check our data over 5 years and see how accurate we really were in our predictions. They came back to us and said "You are not as good as you think you are. You were not 100% accurate. You turned out to be 94.8% accurate." We don't claim to be 100% accurate... Nothing is. However, we do know that we build in current market data and look forward rather than backward. We utilize that in our analytical approaches and that is what gives us our accuracy.

Client Quotes

"Powerful stuff. In my 20 years of Marketing, I have never seen such valuable data on my drug brands." Specialist Team Leader, Pfizer

"It provides a level of insight which has been difficult to obtain using existing tools. The team were impressed by its ability to predict market share movements based on mix investment decisions." Brand Manager, GlaxoSmithKline

"It actually does what it says on the tin." Business Intelligence Manager, Boehringer Ingelheim.

"Your system allowed us all to fully understand just how our overall company and its brands were perceived versus our competitors and what we were required to do in order to grow. Importantly, having a tool available that allowed us to predict whether or not our market share would grow or decline was invaluable as it allowed us for the first time to realistically evaluate our efforts and investments." CEO, AstraZeneca

"We always had the problem that we had a lot of data but it still required guesswork and gut feeling to get us to our strategic marketing decisions. I wasn't sure you would be able to show me more than I already knew. However, this workshop really showed me how to connect the data and the decisions and we now have repeatable improving sales results from implementing this!" Attendee from Eularis Workshop on ROI

Why Invest In These Analytics?

Independent research on our system showed an accuracy of 94.8% over several years for what we said our Clients' brands would gain in market share from following our recommendations, and what they actually gained.

Even if not budgeted for, the System pays for itself with the ongoing rise in market share from accurate message focus and marketing mix allocation.

You get a few key specific actionable recommendations that will have maximum impact on your brand sales/market share over the next 6 months.

Eularis' Analytics offer brands the bottom line facts: which messages, which specific sales and marketing activities (e.g. sales, advertising, journal write-ups, CME's, patient programs, etc.) are truly impacting a brand's prescription sales - by how much - and how should the marketing mix budget be allocated for maximum $ results moving forward.

CONTACT US TODAY FOR ANY FURTHER INFORMATION ON ANY ASPECT OR TO SCHEDULE A MEETING FOR A DEMONSTRATION.

'ROI In Pharma Marketing'

Download Free Report Here

Only company email addresses are accepted for this so if you use your hotmail, yahoo, gmail, aol, comcast etc. email addresses, they will be rejected.

Your email address will be 100% protected and will never, ever be shared.

Only available to employees of Healthcare Companies including Pharmaceutical, Biotech, Medical Devices, Animal Health. If you have a Healthcare brand to market or sell, then you are likely to get in.